Brain Scientific Will Present EEG Devices To Industry Professionals at ASET 2019 Annual Conference

NEW YORK, Aug. 16, 2019 (GLOBE NEWSWIRE) -- Brain Scientific Inc. (OTC:BRSF) (“Brain Scientific” or “Company”), a medical device company combining brain analysis software with wireless sensor technologies for teleneurology solutions, today announced that its wholly-owned subsidiary, MemoryMD, Inc., will present the NeuroCap and NeuroEEG™, the Company’s two FDA-cleared devices for EEG tests, to industry experts at the ASET 2019 Annual Conference taking place in Kansas City from August 15 - 17, 2019.

The Neurodiagnostic Society is the largest national professional association for individuals involved in the study and recording of electrical activity in the brain and nervous system. The Society’s ASET Annual Conference is attended by renowned EEG technicians, technologists and laboratory managers from all over the world.

“The ASET Conference is a must attend event for all neurodiagnostic professionals,” stated Irina Nazarova, Marketing Director of Brain Scientific. “We will leverage the Conference’s broad platform as a business development opportunity and to familiarize industry professionals with NeuroCap and NeuroEEG.”

MemoryMD welcomes ASET attendees to visit Booth #414 at the Sheraton Kansas City Hotel at Crown Center Exhibition Hall, where there will be demonstrations of how NeuroCap and NeuroEEG can help improve patient care.

About Brain Scientific
Brain Scientific is a healthcare technology company developing next generation teleneurology solutions. The Company’s smart diagnostic devices and sensors simplify administration, shorten scan time and cut costs, allowing clinicians to make rapid decisions remotely and bridge the widening gap in access to neurological care. To learn more about our corporate strategy, devices or for investor relations please visit or email us at

About The Neurodiagnostic Society Annual Conference (ASET)
The ASET Annual Conference is the premier education and exposition opportunity for Neurodiagnostic technologists in the country. It is the must attend event for all neurodiagnostic professionals whether you are a technologist, laboratory manager, physician or representing a supplier. 

Forward-Looking Statements
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Forward-looking statements, which involve assumptions and describe our future plans, strategies and expectations, are generally identifiable by use of the words “may,” “should,” “would,” “will,” “could,” “scheduled,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” “seek” or “project” or the negative of these words or other variations on these words or comparable terminology. Such forward-looking statements are not meant to predict or guarantee actual results, performance, events or circumstances, and may not be realized because they are based upon the Company's current projections, plans, objectives, beliefs, expectations, estimates and assumptions, and are subject to a number of risks and uncertainties and other influences, many of which the Company has no control. Actual results and the timing of certain events and circumstances may differ materially from those described by the forward-looking statements as a result of these risks and uncertainties. Factors that may influence or contribute to the inaccuracy of the forward-looking statements or cause actual results to differ materially from expected or desired results may include, without limitation, the Company's inability to obtain additional financing, the significant length of time and resources associated with the development of our products and related insufficient cash flows and resulting illiquidity, the Company's inability to expand its business, significant government regulation of medical devices and the healthcare industry, lack of product diversification, volatility in the price of the Company's raw materials and the Company's failure to implement the Company's business plans or strategies. These and other factors are identified and described in more detail in the Company's filings with the SEC. The Company does not undertake to update these forward-looking statements.

A photo accompanying this announcement is available at

Primary Logo

MemoryMD's booth at the ASET 2019 conference

MemoryMD's booth at the ASET 2019 conference
Source: Brain Scientific